Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid Neoplasms
Katherine Tarlock(Center for Cancer and Blood Disorders), Ann Dahlberg(Seattle Children's Hospital), Paul A. Carpenter(Fred Hutch Cancer Center), Ted Gooley(Fred Hutch Cancer Center), Todd M. Cooper(Seattle Children's Hospital), Corinne Summers(Seattle Children's Hospital), Emily Merkel(Seattle Pacific University), Robert G. Irwin(Mary Bridge Children's Health Center), Ross Goshorn(Providence Sacred Heart Medical Center), Monica S. Thakar(Fred Hutch Cancer Center), Aleksandra Petrović(Seattle Children's Hospital), Marie Bleakley(Unknown)
Cited by 0
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|247
Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2014|210
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
|Transplantation and Cellular Therapy|2022|130